GeneTether Therapeutics (XCNQ:GTTX) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is GeneTether Therapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. GeneTether Therapeutics's Free Cash Flow for the three months ended in Dec. 2023 was C$-0.04 Mil. GeneTether Therapeutics's Revenue for the three months ended in Dec. 2023 was C$0.00 Mil. Therefore, GeneTether Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, GeneTether Therapeutics's current FCF Yield % is -80.38%.

The historical rank and industry rank for GeneTether Therapeutics's FCF Margin % or its related term are showing as below:

XCNQ:GTTX's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -141.025
* Ranked among companies with meaningful FCF Margin % only.

GeneTether Therapeutics FCF Margin % Historical Data

The historical data trend for GeneTether Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneTether Therapeutics FCF Margin % Chart

GeneTether Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Margin %

GeneTether Therapeutics Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial								-	-	-	-	-

Competitive Comparison of GeneTether Therapeutics's FCF Margin %

For the Biotechnology subindustry, GeneTether Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GeneTether Therapeutics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GeneTether Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where GeneTether Therapeutics's FCF Margin % falls into.

GeneTether Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

GeneTether Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-0.624	/	0
	=	%

GeneTether Therapeutics's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.035	/	0
	=	%

GeneTether Therapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of GeneTether Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

GeneTether Therapeutics (XCNQ:GTTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneTether Therapeutics Inc (XCNQ:GTTX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

301-1665 Ellis Street, c/o Pushor Mitchell LLP, Kelowna, BC, CAN, V1Y 2B3

Website

https://www.genetether.com

GeneTether Therapeutics Inc is a genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. It is engaged in creating gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin.

GeneTether Therapeutics (XCNQ:GTTX) Headlines

No Headlines